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Capsule summary:
We show that nasopharyngeal microbiota are coated by different 23 immunoglobulin isotypes in healthy individuals and with IgG in X-linked 24 agammaglobulinemia (XLA) patients treated with immunoglobulin replacement therapy. Respiratory diseases are important causes of death, which collectively account for 36 more than 1 in 10 of all deaths worldwide (WHO). Pathobionts, potential pathogenic bacteria 37 which under normal circumstances are present as harmless microorganisms, can be found 38 embedded in the nasopharyngeal commensal microbiota. Interestingly, the upper airway 39 microbiome composition seems very similar to that of the lung, and pathobionts present in the 40 nasopharynx can be a primary source of lower respiratory tract infections 1 . Several elements 41 participate in respiratory mucosal barrier against invasive pathobionts including the 42 commensal microbiota and glands that secrete and create an antimicrobial mucus barrier 43 containing antimicrobial peptides, immunoglobulins and other soluble factors. Secretory 44 immunoglobulin A (sIgA) and sIgM are transported through nasopharynx epithelial cells by 45 polymeric Ig receptor (pIgR), and IgG by neonatal FcR (FcRn). Transepithelial transport of 46
IgD has not been documented, but IgD is found in nasopharynx secretions 2 perhaps deriving 47 from paracellular diffusion through cell junctions. 48 sIgA is the predominant antibody isotype in human nasopharyngeal secretions and it is 49 assumed that the majority of sIgA targets the resident commensal microbiota, inhibiting their 50 penetration via agglutination within the mucus layer, thereby reinforcing commensalism and 51 increasing microbiota diversity 3 . High-affinity sIgA appears to neutralize microbial toxins and 52 invasive pathogens in the absence of complement fixation 3 . Interestingly, Fadallah et al 4 53
reported recently that Selective IgA Deficiency (SIgADef) patients display mild dysbiosis 54 with expansion of some pathobiont species in their feces as compared to healthy controls, 55 although these patients are not abnormally susceptible to intestinal infections 4 . On the other 56 hand, recurrent pulmonary infections constitute the most prevalent comorbidity in SIgADef 57 patients 4 , suggesting that sIgA may have tissue-specific roles in immune defense, especially 58 in the respiratory tract. A better understanding of immunoglobulins coating nasopharynx 59 microbiota in healthy individuals could provide an important basis for the prevention of 60 respiratory illnesses in some cases of humoral immunodeficiency. 61
To better understand the role for IgA (and other Ig isotypes) in regulating 62
nasopharyngeal microbial communities, we analyze nasopharyngeal samples to detect Ig-63 bound microbes followed by 16S ribosomal RNA (rRNA) sequencing (Ig-seq) to determine 64 the type of bacteria targeted by each Ig isotype. We stained nasopharyngeal samples with 65 anti-human IgA, IgM, IgD and IgG antibodies and measured the immunoglobulin-bound 66 populations using a flow cytometer-based assay 5 . The gating strategy for immunoglobulin 67 staining of human nasopharynx microbiota is shown in Fig E1 ( E1B ). Next we performed flow sorting of IgA-bound nasopharyngeal microbiota followed by 72 16S rRNA sequencing (IgA-seq) on a fraction of samples (n=4) ( Fig E2A) . Beta diversity 73
shows the extent of difference in microbiota community composition from different 74 environments or conditions. The beta diversity, based on Bray-Curtis distance matrix and 75 subjected to Principle Coordinate Analysis, suggest that bacteria derived from IgA + and IgA -76 fractions cluster distinctly, however, permutational multivariate analysis of variance 77 (PERMANOVA) of the two fractions was not significantly different ( Fig E2A, B) . The alpha 78 diversity and the Shannon Diversity Index (a combined measure of evenness and number of 79 bacteria) was lightly decreased in 16S rRNA sequences derived from IgAfraction ( Fig E2C) . 80
However, both IgA + and IgAfractions exhibited equal distributions of rare and abundant 81 genera and thus IgA appears to target nasopharyngeal commensals irrespective of their 82 frequency ( Fig E2D) . These results suggest that under homeostatic conditions, sIgA bind to a 83 broad repertoire of bacteria present in nasopharyngeal microbiota including both commensals 84 and pathobionts 3 . 85
Most SIgADef patients have a mild clinical phenotype 4 , which may result from the 86 ability of other Ig isotypes to functionally replace IgA. Increased IgD + IgM -B cell populations 87 and increased soluble IgD levels have been described in healthy human upper respiratory 88 mucosa 2 . Therefore, even if IgM and IgD have the same V region and the same antigen 89 specificity, nasopharynx/respiratory B cells apparently switch from IgM to secrete IgD, 90 suggesting some functional advantage of the latter. The IgD hinge region linking is longer and 91 more flexible than that of IgM thereby facilitating IgD binding to antigens at lower 92 concentrations and in immune complexes 2 . Still, sIgM binds some residual bacteria in the 93 nasopharynx ( Fig E1) , suggesting that IgM may participate in microbiota agglutination in the 94 steady-state. On the other hand, we found that a vast majority (86%) of the nasopharynx 95 microbiota is targeted by secreted IgD in healthy individuals ( Fig E1) . We observed that up to 96 60% of nasopharynx microbiota are double SIgA + IgD + coated (Fig 1A, B ). We performed 97 flow sorting to isolate IgD-bound microbiota and 16S rRNA sequencing to identify the 98 microbes specifically targeted by IgD ( Fig 1C) . The IgD + SIgAfraction showed a higher 99 microbial diversity as compared to SIgA + IgD -( Fig 1D) . The beta diversity based on Bray-100
Curtis distances was also different ( Fig 1E) , suggesting that IgD bind specifically to bacteria 101 not targeted by SIgA. IgD + SIgAfraction exhibited an enrichment in Proteobacteria phyla 102
(including Haemophilus and Moraxella genus) and the pathobionts Pseudomonas and 103
Escherichia-Shigella ( Fig 1F) . Previous studies showed that IgD somatic hypermutation 104 within the mucus layer of human respiratory tract and we found that approximately 70% of 121 the microbiota present in nasopharynx secretions are targeted by IgG in healthy individuals 122 ( Fig E1) . These results demonstrate that human IgG may opsonize a wide range of 123 nasopharynx microbiota under homeostatic conditions. 16S rRNA sequencing of IgG-bound 124 bacteria allowed identification of their taxonomy ( Fig E3A) . We observed that the IgG + 125 fraction have reduced alpha diversity (Shannon index) comparatively to the IgGfraction ( Fig  126   E3B ), suggesting that IgG bind selectivity to their target and are less polyreactive than IgA. 127
The beta diversity based on Bray-Curtis distance was also significantly different in terms of 128 both abundance and presence/absence of different OTUs ( Fig E3C) . IgG + fraction exhibited a 129 significant decrease in binding in different genera, especially from Proteobacteria phylum 130 (Betaproteobacteria, Campylobacterales, Enterobacteriales, Pseudomonadales) ( Fig E3D) . 131
Members of Proteobacteria phylum are reported to be weak inducers of systemic IgG 132 responses 5 and we found that IgG bind weakly to genera from Proteobacteria in nasopharynx 133 of healthy individuals. Using the double binding with IgA and IgG antibodies we observed 134 that about 54% of nasopharynx bacteria are double SIgA + IgG + coated, and the level of IgG-135 only coated is low (16%) (Fig E3E, F) . This data suggest that 77% of microbiota normally 136 coated by SIgA are also coated with IgG, demonstrating a convergence of IgA and IgG 137 responses toward the same microbial targets under homeostatic conditions. Sequencing of 138 flow sorted IgG + SIgAand SIgA + IgGbacteria ( Fig E3G) showed that alpha diversity 139 (Shannon index) ( Fig E3H) and beta diversity (based on Bray-Curtis distance) (not showed) 140
were not significantly different between IgG + SIgAand SIgA + IgGfractions. We observed 141 only a small enrichment on Bacteroidetes on IgG-only coated fraction ( Fig E3I) . Previous 142 studies showed that human and mice IgG recognized Bacteroides that belongs to this 143 phylum 7 . However, we conclude that IgG recognizes a diverse array of both nasopharynx 144 pathobionts and commensal bacteria 7 . SIgADef patients have an increased anti-commensal 145
IgG response associated with reduced systemic inflammation 5 , our results are consistent with 146 the notion that IgG may provide a layer of mucosal protection during IgA deficiency. 147
Immunoglobulin (IgG) replacement therapy (IVIg) has been used extensively in the 148 treatment of primary and secondary immunodeficiency diseases. With IVIg therapy, X-linked 149 agammaglobulinaemia (XLA-BTK) patients (characterized by a near-complete lack of Igs) 150 have a significant reduction in the occurrence of respiratory tract infections and these patients 151 may live a relatively healthy life 9 . We next studied the immunoglobulins coating of 152 nasopharynx microbiota in IVIg treated XLA-BTK patients. XLA-BTK patients lack IgA, 153 IgM and IgD nasopharynx microbiota binding (Fig 2A) . On the other hand, IVIg therapy 154 restore the secretion of nasopharynx IgG (not shown) and enhances IgG nasopharynx 155 microbiota binding (Fig 2A) . However, despite this increase in IgG coating, XLA-BTK 156 patients exhibit nasopharyngeal microbiota dysbiosis. The beta diversity based on Bray-Curtis 157 distance was significantly different in terms of both abundance and presence/absence of 158 different OTUs ( Fig 2B) and have also a low alpha microbial diversity (Shannon index) 159 comparatively to healthy individuals ( Fig 2C) . XLA-BTK patients exhibited a significant 160 enrichment in Proteobacteria phyla ( Fig 2D) and different pathobiont genera, especially 161
Streptococcus (and Streptococcus pneumoniae specie, not shown), Moraxella, Alloiococcus, 162
Bacteroides, mucus-degrading Mucispirillum among others commensals ( Fig 2F) . For 163 example, IgG bind weakly to genera from Proteobacteria phylum in healthy ( Fig E3D) , 164
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Ghozlane and for the assistance with the data analysis. We thank members of the Di Santo Swabs were thawed and vortexed for 1 minute at 2500 rpm to insure complete sample 31 recovery. Samples was transferred in a 96 well deep-well plate and centrifuged at 16.000g for 32 10 minutes at 4°C to pellet cells and accompanying microbes. Supernatants were recovered 33 and stored at -80°C until analysis using a TECAN Evo 75 robot. 34 cytometry assay was described previous 2 . Briefly, the bacterial pellet was washed and 37 resuspended in flow cytometry buffer (1x-PBS, 2% BSA, 0.02% w/v sodium azide) with 38 SYBR Green (1/10000 (v/v) dilution, Invitrogen) incubated 30 min on ice. After, bacterial 39 suspension was washed twice and pelleted by centrifugation at 16.000g for 10 min. In our study, we are performing the extraction of total genomic DNA from swabs 61 samples, using the TECAN Freedom EVOware workstation, and the NucleoSpin® 96 62 until its use. The concentration of extracted DNA is determined using TECAN (QuantiFluor® 70 ONE dsDNA System, Promega), and DNA integrity and size were also confirmed with the 71 Agilent 2100 Bioanalyzer (Agilent Technologies, USA). The V3-V4 region of the bacterial 72 16S rRNA region were PCR amplified with V3-340F (CCTACGGRAGGCAGCAG) and 73 V4-805R (GGACTACHVGGGTWTCTAAT) containing a primer linker, primer pad, unique 74 8-mer Golay barcode which was used to tag PCR products from respective samples and 75 negative control. PCR reactions consisted of 18 µl of AccuPrime Pfx SuperMix (12344-040; 76 Invitrogen), 0.5 µl of each primers and 1 µl of DNA (10 ng). PCR was carried out as follows: 77 95 °C for 2 min, 30 cycles of 95 °C for 20 s, 55 °C for 15 s and 72 °C for 1 min, and a final 78 extension step at 72 °C for 10 min on a Biorad thermocycler. PCR products were cleaned 79 using NucleoMag magnetic purification beads (MACHEREY-NAGEL Kit) following the 80 protocol, quantified with the QuantiFluor® ONE dsDNA kit (Promega), and pooled in equal 81 amounts of each PCR product. Library pools were loaded at 12pM with a 15% PhiX spike for 82 diversity and sequencing control, onto a v3 300-bp paired end reads cartridge for sequencing 83 on the Illumina MiSeq NGS platform. 84 85
Sequence processing and statistical analysis 86
After removing reads containing incorrect primer or barcode sequences and sequences 87 with more than one ambiguous base, we recovered from 53 samples a total of 3.090.252 reads 88 (58.307 reads on average). The bioinformatics analysis was performed as previously 89 described 4 . Briefly, amplicons were clustered into operational taxonomic units (OTU) with 90 VSEARCH (v1.4) and aligned against the SILVA database. The input amplicons were then 91 mapped against the OTU set to get an OTU-abundance table containing the number of reads 92 associated with each OTU. The normalization, statistical analyses and multiple visualization 93 were performed with SHAMAN (SHiny application for Metagenomic Analysis 94 (shaman.c3bi.pasteur.fr) based on R software. 95
